Daily Economic News – China Securities Regulatory Commission Updates Guidelines for Science and Technology Innovation Companies
In a recent update, the China Securities Regulatory Commission announced revisions to the “Guidelines for the Evaluation of Science and Technology Innovation Attributes (Trial).” The updated guidelines, set to be implemented immediately, aim to enhance the requirements for companies seeking to be listed on the Science and Technology Innovation Board.
According to AI News, the revised guidelines now include increased criteria for R&D investment, the number of invention patents, and the compound growth rate of operating income. These updates are intended to encourage science and technology companies to prioritize research investment, industrialize research results, and improve overall enterprise quality.
Moving forward, the China Securities Regulatory Commission will work closely with the Shanghai Stock Exchange to ensure the implementation of these rules. The focus will be on supporting companies that align with national strategies, possess key core technologies, demonstrate exceptional innovation capabilities, and rely on core technologies for production and operations.
The Science and Technology Innovation Board will prioritize listing enterprises with high market recognition, a strong social image, and significant growth potential. The goal is to promote industrial innovation through technological advancements and leverage the board’s functions effectively.
By refining the evaluation criteria and emphasizing the importance of research investment and innovation, the China Securities Regulatory Commission seeks to foster a more robust and competitive landscape for science and technology companies in the market.